McDonald’s: E. Coli Continues To Infect Results; Analysts Expect Value Offerings, Marketing To Drive Performance

McDonald’s continued to edge higher in early trading on Tuesday, despite the company reporting a decline in fourth-quarter revenues. Latest Ratings for MCD Date Firm Action From To Mar 2022 Northcoast Research Downgrades Buy Neutral Jan 2022 Barclays Maintains Overweight Jan 2022 Keybanc Maintains Overweight View More Analyst Ratings for MCD View the Latest Analyst…

Read More